Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections

US Patent 9345663 · Granted May 24, 2016

Estimated economic value: $210,253,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Formulations of aminoglycoside and fosfomycin in combination for treatment of ve2019
Formulations of aminoglycosides and fosfomycin in a combination having improved 2019
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infectio2017
Formulations of aminoglycoside and fosfomycin combinations and methods and syste2016
Formulations of aminoglycoside and fosfomycin combinations and methods and syste2016
Formulations of aminoglycoside and fosfomycin combinations and methods and syste2016
Formulations of aminoglycoside and fosfomycin combinations and methods and syste2016
Formulations of aminoglycosides and fosfomycin in a combination having improved 2016
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmona2014
Formulations of aminoglycoside and fosfomycin combinations and methods and syste2014
Methods to administer formulations of aminoglycoside and fosfomycin combination 2014
Aminoglycoside and fosfomycin combination for treatment of ventilator associated2014